Atwood & Palmer’s TherapeuticsMD TXMD Stock Holding History

Atwood & Palmer’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-150	Closed	-$43K	–	334
2016 Q4	$43K	Hold	150	–	–	0.01%	178
2016 Q3	$51K	Hold	150	–	–	0.01%	169
2016 Q2	$64K	Hold	150	–	–	0.01%	167
2016 Q1	$48K	Hold	150	–	–	0.01%	174
2015 Q4	$78K	Buy	+150	New	+$55.4K	0.01%	179

Other funds holding TXMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Atwood & Palmer's TXMD Position: Q1 2017 in Review

Atwood & Palmer sold out of TherapeuticsMD (TXMD) in Q1 2017, closing a stake of 150 shares — an estimated $43K sold.

Atwood & Palmer first reported a position in TXMD in Q4 2015 and held it in 5 quarters. The position peaked at $78K in Q4 2015. 138 funds tracked by Wall St. Rank hold TXMD as of Q1 2017.

Atwood & Palmer reported no remaining TherapeuticsMD position as of Q1 2017 after selling out during the quarter.
Atwood & Palmer sold 150 TherapeuticsMD shares in Q1 2017, an estimated $43K.
Atwood & Palmer first reported a position in TherapeuticsMD in Q4 2015 and held it in 5 quarters.
Atwood & Palmer's TherapeuticsMD position peaked at $78K in Q4 2015.
138 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2017.

Based on Atwood & Palmer's 13F filing for Q1 2017, filed 28 Apr 2017.